Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ KRCA 0008
Click to view available options
Quantity:
10 mg
50 mg
Description
KRCA 0008 is a potent Ack1 and anaplastic lymphoma kinase (ALK) dual inhibitor (IC50 values are 4 and 12 nM respectively). Inhibits lung cancer H3122 cell proliferation (IC50 = 80 nM). Attenuates H3122 cell xenograft tumor growth in mice. Orally bioavailable.
Specifications
Specifications
| Purity | >99% |
| Quantity | 50 mg |
| Product Type | KRCA 0008 |
| Molecular Weight (g/mol) | 609.12 |
| Inhibitors | KRCA 0008 |
For Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction